BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19487154)

  • 1. Helping secure the global pharmaceutical manufacturing supply chain.
    Lawson M
    Drug Discov Today; 2009 Jun; 14(11-12):533-5. PubMed ID: 19487154
    [No Abstract]   [Full Text] [Related]  

  • 2. Building biomanufacturing capacity--the chapter and verse.
    Kamarck ME
    Nat Biotechnol; 2006 May; 24(5):503-5. PubMed ID: 16680126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Industrially feasible alternative approaches in the manufacture of solid dispersions: a technical report.
    Karanth H; Shenoy VS; Murthy RR
    AAPS PharmSciTech; 2006 Oct; 7(4):87. PubMed ID: 17233539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manufacturing in China.
    Med Device Technol; 2005 Nov; 16(9):48-9. PubMed ID: 16438451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Data completeness--the Achilles heel of drug-target networks.
    Mestres J; Gregori-Puigjané E; Valverde S; Solé RV
    Nat Biotechnol; 2008 Sep; 26(9):983-4. PubMed ID: 18779805
    [No Abstract]   [Full Text] [Related]  

  • 6. Manufacturing and standardizing allergen extracts in Europe.
    Larsen JN; Houghton CG; Løwenstein H; Lombardero M
    Clin Allergy Immunol; 2004; 18():433-55. PubMed ID: 15042928
    [No Abstract]   [Full Text] [Related]  

  • 7. What can Johnson & Johnson do to remain a giant in the health care industry?
    Carter T
    J Hosp Mark Public Relations; 2002; 14(1):93-103. PubMed ID: 12569997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opting for clean manufacturing.
    Schuy KJ
    Med Device Technol; 2004 Jun; 15(5):43. PubMed ID: 15285490
    [No Abstract]   [Full Text] [Related]  

  • 9. Medium term planning of biopharmaceutical manufacture using mathematical programming.
    Lakhdar K; Zhou Y; Savery J; Titchener-Hooker NJ; Papageorgiou LG
    Biotechnol Prog; 2005; 21(5):1478-89. PubMed ID: 16209554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging technologies supporting chemical process R&D and their increasing impact on productivity in the pharmaceutical industry.
    Rubin AE; Tummala S; Both DA; Wang C; Delaney EJ
    Chem Rev; 2006 Jul; 106(7):2794-810. PubMed ID: 16836299
    [No Abstract]   [Full Text] [Related]  

  • 11. Medical packaging: more for less?
    Andrews J; Hunt N
    Med Device Technol; 1999 Apr; 10(3):26-8. PubMed ID: 10387624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multiscale simulation framework for the manufacturing facility and supply chain of autologous cell therapies.
    Wang K; Liu Y; Li J; Wang B; Bishop R; White C; Das A; Levine AD; Ho L; Levine BL; Fesnak AD
    Cytotherapy; 2019 Oct; 21(10):1081-1093. PubMed ID: 31445816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Industrial hygiene in the pharmaceutical industry.
    Guest I; Newton D
    Occup Med; 1997; 12(1):81-94. PubMed ID: 9153054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput and parallel screening methods in asymmetric hydrogenation.
    Jäkel C; Paciello R
    Chem Rev; 2006 Jul; 106(7):2912-42. PubMed ID: 16836304
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in the business of culture.
    Pissarra Pde N
    Nat Biotechnol; 2004 Nov; 22(11):1355-6. PubMed ID: 15529153
    [No Abstract]   [Full Text] [Related]  

  • 16. The rise of foreign agents. Drugs and other medical products from offshore suppliers can offer tremendous savings, but safety has become an increasing concern.
    Rhea S
    Mod Healthc; 2008 May; 38(21):28-30. PubMed ID: 18711901
    [No Abstract]   [Full Text] [Related]  

  • 17. Reaping rapid rewards.
    Watmough M
    Med Device Technol; 2000 Nov; 11(9):20-2. PubMed ID: 11146865
    [No Abstract]   [Full Text] [Related]  

  • 18. At-line quantitative ion mobility spectrometry for direct analysis of swabs for pharmaceutical manufacturing equipment cleaning verification.
    Strege MA; Kozerski J; Juarbe N; Mahoney P
    Anal Chem; 2008 Apr; 80(8):3040-4. PubMed ID: 18333625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection for manufacturing, not research.
    Nat Rev Drug Discov; 2003 Oct; 2(10):766. PubMed ID: 14579809
    [No Abstract]   [Full Text] [Related]  

  • 20. Permitting product liability litigation for FDA-approved drugs and devices promotes patient safety.
    Kesselheim AS
    Clin Pharmacol Ther; 2010 Jun; 87(6):645-7. PubMed ID: 20485322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.